Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 35, 2018 - Issue 1
773
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Circadian gene methylation in rotating-shift nurses: a cross-sectional study

ORCID Icon, ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 111-121 | Received 04 May 2017, Accepted 02 Oct 2017, Published online: 16 Nov 2017

References

  • Akashi M, Okamoto A, Tsuchiya Y, Todo T, Nishida E, Node K. 2014. A positive role for PERIOD in mammalian circadian gene expression. Cell Rep. 7:1056–64. doi:10.1016/j.celrep.2014.03.072.
  • Alexander M, Burch JB, Steck SE, Chen CF, Hurley TG, Cavicchia P, Shivappa N, Guess J, Zhang H, Youngstedt SD, et al. 2017. Case-control study of candidate gene methylation and adenomatous polyp formation. Int J Colorectal Dis. 32:183–92. doi:10.1007/s00384-016-2688-1.
  • Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. 2001. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron. 30:525–36. doi:10.1016/S0896-6273(01)00302-6.
  • Barault L, Ellsworth RE, Harris HR, Valente AL, Shriver CD, Michels KB. 2013. Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA. PLoS One. 8:e55896. doi:10.1371/journal.pone.0055896.
  • Bengesser SA, Reininghaus EZ, Lackner N, Birner A, Fellendorf FT, Platzer M, Kainzbauer N, Tropper B, Hormanseder C, Queissner R, et al. 2016. Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL. World J Biol Psychiatry. 1–9. doi:10.1080/15622975.2016.1231421.
  • Bhatti P, Zhang Y, Song X, Makar KW, Sather CL, Kelsey KT, Houseman EA, Wang P. 2015. Nightshift work and genome-wide DNA methylation. Chronobiol Int. 32:103–12. doi:10.3109/07420528.2014.956362.
  • Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, Rota F, Costa G. 2010. Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol Int. 27:1093–104. doi:10.3109/07420528.2010.490065.
  • Bracci M, Manzella N, Copertaro A, Staffolani S, Strafella E, Barbaresi M, Copertaro B, Rapisarda V, Valentino M, Santarelli L. 2014. Rotating-shift nurses after a day off: Peripheral clock gene expression, urinary melatonin, and serum 17-beta-estradiol levels. Scand J Work Environ Health. 40:295–304. doi:10.5271/sjweh.3414.
  • Bulla A, De Witt B, Ammerlaan W, Betsou F, Lescuyer P. 2016. Blood DNA Yield but Not Integrity or Methylation Is Impacted After Long-Term Storage. Biopreserv Biobank. 14:29–38. doi:10.1089/bio.2015.0045.
  • Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA. 2000. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell. 103:1009–17. doi:10.1016/S0092-8674(00)00205-1.
  • Cheng J, Tang L, Hong Q, Ye H, Xu X, Xu L, Bu S, Wang Q, Dai D, Jiang D, et al. 2014. Investigation into the promoter DNA methylation of three genes (CAMK1D, CRY2 and CALM2) in the peripheral blood of patients with type 2 diabetes. Exp Ther Med. 8:579–84. doi:10.3892/etm.2014.1766.
  • Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. 2000. MethyLight: A high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28:E32. doi:10.1093/nar/28.8.e32.
  • Farre P, Jones MJ, Meaney MJ, Emberly E, Turecki G, Kobor MS. 2015. Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin. 8:19. doi:10.1186/s13072-015-0011-y.
  • Flanagan JM, Brook MN, Orr N, Tomczyk K, Coulson P, Fletcher O, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow A, et al. 2015. Temporal stability and determinants of white blood cell DNA methylation in the breakthrough generations study. Cancer Epidemiol Biomarkers Prev. 24:221–29. doi:10.1158/1055-9965.EPI-14-0767.
  • Friso S, Udali S, De Santis D, Choi SW. 2017. One-carbon metabolism and epigenetics. Mol Aspects Med. 54:28–36. doi:10.1016/j.mam.2016.11.007.
  • Hanoun M, Eisele L, Suzuki M, Greally JM, Huttmann A, Aydin S, Scholtysik R, Klein-Hitpass L, Duhrsen U, Durig J. 2012. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One. 7:e34347. doi:10.1371/journal.pone.0034347.
  • Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. 2010a. CLOCK in breast tumorigenesis: Genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 70:1459–68. doi:10.1158/0008-5472.CAN-09-3798.
  • Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. 2010b. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila). 3:539–48. doi:10.1158/1940-6207.CAPR-09-0127.
  • Jacobs DI, Hansen J, Fu A, Stevens RG, Tjonneland A, Vogel UB, Zheng T, Zhu Y. 2013. Methylation Alterations at Imprinted Genes Detected Among Long Term Shiftworkers. Environ Mol Mutagen. 54:141–46. doi:10.1002/em.v54.2.
  • James FO, Cermakian N, Boivin DB. 2007. Circadian rhythms of melatonin, cortisol, and clock gene expression during simulated night shift work. Sleep. 30:1427–36. doi:10.1093/sleep/30.11.1427.
  • Langevin SM, Houseman EA, Accomando WP, Koestler DC, Christensen BC, Nelson HH, Karagas MR, Marsit CJ, Wiencke JK, Kelsey KT. 2014. Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients. Epigenetics. 9:884–95. doi:10.4161/epi.28575.
  • Lee S, Donehower LA, Herron AJ, Moore DD, Fu L. 2010. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One. 5:e10995. doi:10.1371/journal.pone.0010995.
  • Lin Q, Ding H, Zheng Z, Gu Z, Ma J, Chen L, Chan P, Cai Y. 2012. Promoter methylation analysis of seven clock genes in Parkinson’s disease. Neurosci Lett. 507:147–50. doi:10.1016/j.neulet.2011.12.007.
  • Liu R, Jacobs DI, Hansen J, Fu A, Stevens RG, Zhu Y. 2015. Aberrant methylation of miR-34b is associated with long-term shiftwork: A potential mechanism for increased breast cancer susceptibility. Cancer Causes Control. 26:171–78. doi:10.1007/s10552-014-0494-z.
  • Lu L, Katsaros D, De La Longrais IA, Sochirca O, Yu H. 2007. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67:10117–22. doi:10.1158/0008-5472.CAN-07-2544.
  • Ma B, Wilker EH, Willis-Owen SA, Byun HM, Wong KC, Motta V, Baccarelli AA, Schwartz J, Cookson WO, Khabbaz K, et al. 2014. Predicting DNA methylation level across human tissues. Nucleic Acids Res. 42:3515–28. doi:10.1093/nar/gkt1380.
  • Milagro FI, Gomez-Abellan P, Campion J, Martinez JA, Ordovas JM, Garaulet M. 2012. CLOCK, PER2 and BMAL1 DNA methylation: Association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol Int. 29:1180–94. doi:10.3109/07420528.2012.719967.
  • Peplonska B, Bukowska A, Gromadzinska J, Sobala W, Reszka E, Lie J-A, Kjuus H, Wasowicz W. 2012. Night shift work characteristics and 6-sulfatoxymelatonin (MT6s) in rotating night shift nurses and midwives. Occup Environ Med. 69:339–46. doi:10.1136/oemed-2011-100273.
  • Reszka E, Peplonska B, Wieczorek E, Sobala W, Bukowska A, Gromadzinska J, Lie JA, Kjuus H, Wasowicz W. 2013. Circadian gene expression in peripheral blood leukocytes of rotating night shift nurses. Scand J Work Environ Health. 39:187–94. doi:10.5271/sjweh.3303.
  • Reszka E, Przybek M. 2016. Circadian Genes in Breast Cancer. Adv Clin Chem. 75:53–70.
  • Reszka E, Przybek M, Muurlink O, Peplonska B. 2017. Circadian gene variants and breast cancer. Cancer Lett. 390:137–45. doi:10.1016/j.canlet.2017.01.012.
  • Samblas M, Milagro FI, Gomez-Abellan P, Martinez JA, Garaulet M. 2016. Methylation on the circadian gene BMAL1 is associated with the effects of a weight loss intervention on serum lipid levels. J Biol Rhythms. 31:308–17. doi:10.1177/0748730416629247.
  • Shi F, Chen X, Fu A, Hansen J, Stevens R, Tjonneland A, Vogel UB, Zheng T, Zhu Y. 2013. Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers. Environ Mol Mutagen. 54:406–13. doi:10.1002/em.v54.6.
  • Shih MC, Yeh KT, Tang KP, Chen JC, Chang JG. 2006. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol Carcinog. 45:732–40. doi:10.1002/mc.20198.
  • Shvetsov YB, Song MA, Cai Q, Tiirikainen M, Xiang YB, Shu XO, Yu H. 2015. Intraindividual variation and short-term temporal trend in DNA methylation of human blood. Cancer Epidemiol Biomarkers Prev. 24:490–97. doi:10.1158/1055-9965.EPI-14-0853.
  • Stevens RG. 1987. Electric power use and breast cancer: A hypothesis. Am J Epidemiol. 125:556–61. doi:10.1093/oxfordjournals.aje.a114569.
  • Stevens RG. 2005. Circadian disruption and breast cancer: From melatonin to clock genes. Epidemiology. 16:254–58. doi:10.1097/01.ede.0000152525.21924.54.
  • Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. 2014. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 64:207–18. doi:10.1093/oxfordjournals.aje.a114569.
  • Stevens RG, Davis S. 1996. The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect. 104(Suppl 1):135–40. doi:10.1289/ehp.96104s1135.
  • Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castano-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, et al. 2011. Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup Environ Med. 68:154–62. doi:10.1136/oem.2009.053512.
  • Stevens RG, Rea MS. 2001. Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 12:279–87. doi:10.1023/A:1011237000609.
  • Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V. 2007. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8:1065–66. doi:10.1016/S1470-2045(07)70373-X.
  • Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. 2016. Blood-based DNA methylation as biomarker for breast cancer: A systematic review. Clin Epigenetics. 8:115. doi:10.1186/s13148-016-0282-6.
  • Taniguchi H, Fernandez AF, Setien F, Ropero S, Ballestar E, Villanueva A, Yamamoto H, Imai K, Shinomura Y, Esteller M. 2009. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 69:8447–54. doi:10.1158/0008-5472.CAN-09-0551.
  • Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. 2002. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci U S A. 99:7728–33. doi:10.1073/pnas.102075599.
  • Xu Z, Bolick SC, DeRoo LA, Weinberg CR, Sandler DP, Taylor JA. 2013. Epigenome-wide association study of breast cancer using prospectively collected sister study samples. J Natl Cancer Inst. 105:694–700. doi:10.1093/jnci/djt045.
  • Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, Liu TC, Hsiao HH, Liu YC, Lin SF. 2006. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 97:1298–307. doi:10.1111/j.1349-7006.2006.00331.x.
  • Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, et al. 2001. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell. 105:683–94. doi:10.1016/S0092-8674(01)00380-4.
  • Zheng SC, Widschwendter M, Teschendorff AE. 2016. Epigenetic drift, epigenetic clocks and cancer risk. Epigenomics. 8:705–19. doi:10.2217/epi-2015-0017.
  • Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T, Hansen J. 2011. Epigenetic impact of long-term shiftwork: Pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int. 28:852–61. doi:10.3109/07420528.2011.618896.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.